EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperoside alleviates postmenopausal osteoporosis via regulating miR‐19a‐5p/IL‐17A axis

Hongqiang An, Chu Chu, Zhen Zhang, Yunhong Zhang, Ran Wei, Bin Wang, Ke Xu, Lihua Li, Yonglin Liu, Gang Li, Xia Li

American Journal of Reproductive Immunology · 2023-07 · 90 (1)

DOI: 10.1111/aji.13709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 08.05.2023. Verfasst von Hongqiang An und 10 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Osteoporosis, Postmenopausal, MicroRNAs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Problem Postmenopausal osteoporosis (PMO) is a common osteoporosis. Hyperoside (Hyp), a natural flavonoid compound, has anti‐osteoporotic effects, but the underlying mechanisms remain poorly understood. Inflammatory cytokine IL‐17A is upregulated in PMO and plays vital roles in bone loss, but the upstream regulatory factors and mechanisms are still unknown. Method of study Twenty PMO patients and 20 healthy control subjects were included to analyze IL‐17A expression changes and screen dys‐regulated miRNAs in the peripheral blood of PMO patients. miR‐19a‐5p mimics and inhibitor were transfected into RAW264.7 osteoclasts, and injected into bilateral ovariectomized (OVX) mice to explore the regulatory effect of miR‐19a‐5p on IL‐17A. OVX mice were randomly grouped and treated with different doses of Hyp to uncover the effective targets for the medicine in PMO disease.

Results

MiR‐19a‐5p was downregulated in PMO patients and the expression level was negatively correlated with that of IL‐17A. miR‐19a‐5p could directly bind to the 3′UTR of IL‐17A and regulate its expression. Both in vitro and in vivo studies demonstrated that miR‐19a‐5p mimics decreased the expression of IL‐17A, RANK and Cathepsin K, while miR‐19a‐5p inhibitor significantly increased the expression of IL‐17A, RANK, and Cathepsin K. Importantly, the Hyp could improve bone structure of OVX mice by enhancing miR‐19a‐5p‐mediated IL‐17A downregulation.

Conclusion

Overall, these data demonstrated that miR‐19a‐5p/IL‐17A axis might serve as novel therapeutic candidate for PMO. Hyp could relieve bone resorption by targeting the miR‐19a‐5p/IL‐17A axis in OVX mice and exhibited prospective for the treatment of PMO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoporosis, PostmenopausalMicroRNAsHumansFemaleAnimalsMiceCathepsin KInterleukin-17Prospective StudiesQuercetin

Stichwörter der Autor:innen

HyperosideIL-17AmiRNA-19a-5ppostmenopausal osteoporosis

Substanzen

Cathepsin KInterleukin-17MicroRNAshyperosideQuercetin

Autor:innen und Institutionen

  • Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • The First Clinical Medical School, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • The People's Hospital of Xintai, Taian, China.
  • School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

An, H., Chu, C., Zhang, Z., Zhang, Y., Wei, R., Wang, B., Xu, K., Li, L., Liu, Y., Li, G., & Li, X. (2023). Hyperoside alleviates postmenopausal osteoporosis via regulating miR‐19a‐5p/IL‐17A axis. American Journal of Reproductive Immunology, 90(1). https://doi.org/10.1111/aji.13709

Vancouver

An H, Chu C, Zhang Z, Zhang Y, Wei R, Wang B, et al. Hyperoside alleviates postmenopausal osteoporosis via regulating miR‐19a‐5p/IL‐17A axis. American Journal of Reproductive Immunology. 2023;90(1). doi:10.1111/aji.13709

BibTeX
@article{An2023,
  author = {An, Hongqiang and Chu, Chu and Zhang, Zhen and Zhang, Yunhong and Wei, Ran and Wang, Bin and Xu, Ke and Li, Lihua and Liu, Yonglin and Li, Gang and Li, Xia},
  title = {Hyperoside alleviates postmenopausal osteoporosis via regulating miR‐19a‐5p/IL‐17A axis},
  journal = {American Journal of Reproductive Immunology},
  year = {2023},
  volume = {90},
  number = {1},
  doi = {10.1111/aji.13709}
}
Kostenlos starten →